These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 25708509

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. VATS pericardiotomy for patients with known malignancy and pericardial effusion: survival and prognosis of positive cytology and metastatic involvement of the pericardium: a case control study.
    Neragi-Miandoab S, Linden PA, Ducko CT, Bueno R, Richards WG, Sugarbaker DJ, Jaklitsch MT.
    Int J Surg; 2008 Apr; 6(2):110-4. PubMed ID: 18329349
    [Abstract] [Full Text] [Related]

  • 5. Mid-Term Efficacy of Subxiphoid Versus Transpleural Pericardial Window for Pericardial Effusion.
    Balla S, Zea-Vera R, Kaplan RA, Rosengart TK, Wall MJ, Ghanta RK.
    J Surg Res; 2020 Aug; 252():9-15. PubMed ID: 32213328
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-Term Outcomes after Video-Assisted Thoracoscopic Pericardiectomy for Pericardial Effusion.
    Mizukami Y, Ueda N, Adachi H, Arikura J, Kondo K.
    Ann Thorac Cardiovasc Surg; 2017 Dec 20; 23(6):304-308. PubMed ID: 28794388
    [Abstract] [Full Text] [Related]

  • 8. Treatment of malignant pericardial effusion.
    Vaitkus PT, Herrmann HC, LeWinter MM.
    JAMA; 1994 Jul 06; 272(1):59-64. PubMed ID: 8007081
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors in the surgical management of pericardial effusion in the patient with concurrent malignancy.
    Cullinane CA, Paz IB, Smith D, Carter N, Grannis FW.
    Chest; 2004 Apr 06; 125(4):1328-34. PubMed ID: 15078742
    [Abstract] [Full Text] [Related]

  • 10. Retrospective comparison of outcomes, diagnostic value, and complications of percutaneous prolonged drainage versus surgical pericardiotomy of pericardial effusion associated with malignancy.
    Patel N, Rafique AM, Eshaghian S, Mendoza F, Biner S, Cercek B, Siegel RJ.
    Am J Cardiol; 2013 Oct 15; 112(8):1235-9. PubMed ID: 23827405
    [Abstract] [Full Text] [Related]

  • 11. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade.
    Maher EA, Shepherd FA, Todd TJ.
    J Thorac Cardiovasc Surg; 1996 Sep 15; 112(3):637-43. PubMed ID: 8800150
    [Abstract] [Full Text] [Related]

  • 12. Technical and prognostic outcomes of double-balloon pericardiotomy for large malignancy-related pericardial effusions.
    Wang HJ, Hsu KL, Chiang FT, Tseng CD, Tseng YZ, Liau CS.
    Chest; 2002 Sep 15; 122(3):893-9. PubMed ID: 12226029
    [Abstract] [Full Text] [Related]

  • 13. Recurrence of pericardial effusion after different procedure modalities in patients with non-small-cell lung cancer.
    Chang LK, Kuo YW, Wu SG, Chung KP, Shih JY.
    ESMO Open; 2022 Feb 15; 7(1):100354. PubMed ID: 34953402
    [Abstract] [Full Text] [Related]

  • 14. Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival.
    Dequanter D, Lothaire P, Berghmans T, Sculier JP.
    Ann Surg Oncol; 2008 Nov 15; 15(11):3268-71. PubMed ID: 18648881
    [Abstract] [Full Text] [Related]

  • 15. Risk factors affecting the survival of patients with pericardial effusion submitted to subxiphoid pericardiostomy.
    Dosios T, Theakos N, Angouras D, Asimacopoulos P.
    Chest; 2003 Jul 15; 124(1):242-6. PubMed ID: 12853529
    [Abstract] [Full Text] [Related]

  • 16. [Percutaneous balloon pericardiotomy in patients with recurrent pericardial effusion].
    Navarro Del Amo LF, Córdoba Polo M, Orejas Orejas M, López Fernández T, Mohandes M, Iñíguez Romo A.
    Rev Esp Cardiol; 2002 Jan 15; 55(1):25-8. PubMed ID: 11784520
    [Abstract] [Full Text] [Related]

  • 17. Risk factors affecting the survival rate in patients with symptomatic pericardial effusion undergoing surgical intervention.
    Mirhosseini SM, Fakhri M, Mozaffary A, Lotfaliany M, Behzadnia N, Ansari Aval Z, Ghiasi SM, Boloursaz MR, Masjedi MR.
    Interact Cardiovasc Thorac Surg; 2013 Apr 15; 16(4):495-500. PubMed ID: 23250960
    [Abstract] [Full Text] [Related]

  • 18. Predictors of hospital discharge in cancer patients with pericardial effusion undergoing surgical pericardial drainage.
    Kazantzis T, Bibas BJ, Dela-Vega AJ, Nabuco P, Lauricella LL, Pêgo-Fernandes PM, Terra RM.
    J Surg Oncol; 2019 Jan 15; 119(1):143-147. PubMed ID: 30466137
    [Abstract] [Full Text] [Related]

  • 19. Eleven years' experience with pericardial-peritoneal window in the management of malignant and benign pericardial effusions.
    Olson JE, Ryan MB, Blumenstock DA.
    Ann Surg Oncol; 1995 Mar 15; 2(2):165-9. PubMed ID: 7728571
    [Abstract] [Full Text] [Related]

  • 20. Systemic chemotherapy in combination with pericardial window has better outcomes in malignant pericardial effusions.
    Çelik S, Lestuzzi C, Cervesato E, Dequanter D, Piotti P, De Biasio M, Imazio M.
    J Thorac Cardiovasc Surg; 2014 Nov 15; 148(5):2288-93. PubMed ID: 24836991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.